Christina M. Laukaitis, MD, PhD, FACP, FACMG

  • Assistant Professor, Cancer Biology - GIDP
  • Assistant Professor, Genetics - GIDP
  • Associate Professor, Medicine
  • Associate Professor, Nutritional Sciences
  • Director, Genetic Consultation and Counseling Services, UAHS Center for Applied Genetics and Genomic Medicine
  • Director, Molecular Genetic Pathology Fellowship Program, Department of Pathology, UA College of Medicine
  • Medical Education Director, Partnership for Native American Cancer Prevention, UA Cancer Center
  • Member, Southwest Environmental Health Sciences Center, UA College of Pharmacy
  • Member, UA Center on Aging

Dr. Laukaitis' professional goal is to understand the genetic and environmental risk factors that predispose individuals to cancer in order to treat neoplasia before cancer develops. Her training and board certification in Medical Genetics have provided her with expertise, and to experience caring for people at high-risk for breast and other cancers due to mutations in BRCA1, BRCA2, APC and mismatch repair genes. In Dr. Laukaitis' laboratory, they seek explanations for high-risk families without identified mutations. Dr. Laukaitis has experience working with WBF and UDCA sample genotyping and experience interpreting genetic data that influences cancer risk.

Research Interests: 

My professional goal is to provide individual risk assessment and counseling to develop a plan for treating neoplasia before metastatic cancer develops in people at high-risk of cancer because of genetic factors. My training and board certification in Medical Genetics have provided me with expertise and experience caring for people at high-risk for breast cancer due to mutations in BRCA1, BRCA2, APC and mismatch repair genes genes. I will couple this with my laboratory background to translate advances understanding additional genes influencing cancer risk into new clinical tests for my patients. I will seek to apply these advances to all of my patients, regardless of racial, ethnic, or socio-economic background. A second research direction addresses appropriate targeting of chemoprevention strategies. I am participating in a project to test the safety of using DFMO and sulindac as a chemopreventive strategy in children with FAP, which we hope to follow with a study of efficacy.

  • MD: University of Illinois at Urbana-Champaign, 2003
  • Undergrad: Butler University - Indianapolis
Honors and Awards
  • National Science Scholar, National Science Foundation, 1991-1995
  • Summer Institute in Statistical Genetics, North Carolina State University, 2005
  • Young Alumni Board, Butler University, 2010-2011
  • Yellen Distinguished Young Investigator Award, Arizona Cancer Center, 2011
  • 40 under 40, Arizona Star - recognizes young leaders in Tucson based on professional accomplishments, leadership qualities and community impact, 2011
  • “Researcher of the Year”, Arizona Chapter, American College of Physicians, 2013
  • Vice President’s Precision Health Advisory Council
  • Internal Medicine Residency Program Core Faculty
  • Laboratory Director, Clinical Laboratory of the University of Arizona Genomics Core
  • Internal Medicine: St. Vincent Hospital & Health Center, Indianapolis, 2006
  • University of Washington Medical Center, Medical Genetics
Board Certifications
  • American Board of Internal Medicine, Internal Medicine - General, 2006
  • American Board of Medical Genetics and Genomics, Clinical Genetics - General, 2009